文献速递血管炎

头颈胸部PET/CT诊断巨细胞动脉炎的前瞻性双盲横断面研究

Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double-Blind, Cross-Sectional Study.
PubMed 文献 · Arthritis Rheumatol · 2019-06-12

GAPS研究纳入64例新疑巨细胞动脉炎(GCA)患者,在启动糖皮质激素72小时内、颞动脉活检前进行飞行时间PET/CT(颅顶至膈肌1mm层厚),由两名医师盲法判读。以颞动脉活检为参照,PET/CT诊断GCA的敏感度为92%(95%CI 62-100%)、特异度为85%(95%CI 71-94%)、阴性预测值为98%(95%CI 87-100%);以6个月临床诊断为参照,敏感度为71%(95%CI 48-89%)、特异度为91%(95%CI 78-97%)。

要点

  • PET/CT以颞动脉活检为参照诊断GCA敏感度92%、特异度85%、阴性预测值98%。
  • 以6个月临床诊断为参照,PET/CT敏感度71%、特异度91%。
  • 20%患者检出临床相关偶然发现,包括7例感染和5例恶性肿瘤。

核心结论

  • 该PET/CT方案诊断GCA准确度高,支持其作为一线检查。
  • 阴性预测值98%提示该检查尤其适用于低风险患者排除GCA。
  • PET/CT在检出血管炎模仿病和主动脉炎方面优于颞动脉活检。

研究设计与样本

  • GAPS为前瞻性、双盲、横断面研究,纳入64例新疑GCA患者。
  • 患者在启动糖皮质激素72小时内、颞动脉活检前接受飞行时间PET/CT,扫描范围从颅顶至膈肌、层厚1mm。
  • 两名有PET经验的医师盲法判读扫描,对GCA全局阳性或阴性做出报告,并按18个动脉节段分级示踪剂摄取。
  • 临床诊断在6个月随访时确认。

主要发现

  • 64例中58例接受颞动脉活检,12例(21%)活检阳性;21例临床诊断为GCA。
  • 以颞动脉活检为参照,PET/CT诊断GCA的敏感度为92%(95%CI 62-100%)、特异度为85%(95%CI 71-94%)、阴性预测值为98%(95%CI 87-100%)。
  • 以临床诊断为参照,PET/CT诊断GCA的敏感度为71%(95%CI 48-89%)、特异度为91%(95%CI 78-97%)。
  • 观察者间信度中等(κ=0.65)。
  • 20%的入组患者有临床相关偶然发现,包括7例感染和5例恶性肿瘤;12例活检阳性GCA患者中5例(42%)有中度或明显主动脉炎。

关键数值与推荐

  • 以颞动脉活检为参照,PET/CT诊断GCA的敏感度为92%(95%CI 62-100%)、特异度为85%(95%CI 71-94%)、阴性预测值为98%(95%CI 87-100%)。
  • 以6个月临床诊断为参照,PET/CT诊断GCA的敏感度为71%(95%CI 48-89%)、特异度为91%(95%CI 78-97%)。
  • 观察者间信度κ=0.65。

临床怎么用

  • 该PET/CT方案可作为新疑GCA的一线检查,尤其适用于低风险患者排除GCA。
  • PET/CT有助于检出血管炎模仿病和主动脉炎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Positron emission tomography/computed tomography (PET/CT) has not been well studied as a first-line test for giant cell arteritis (GCA), due, in part, to historical limitations in visualizing the cranial arteries. The Giant Cell Arteritis and PET Scan (GAPS) study was therefore carried out to assess the accuracy of a newer generation PET/CT of the head, neck, and chest for determining a diagnosis of GCA. METHODS: In the GAPS study cohort, 64 patients with newly suspected GCA underwent time-of-flight PET/CT (1-mm slice thickness from the vertex to diaphragm) within 72 hours of starting glucocorticoids and before undergoing temporal artery biopsy (TAB). Two physicians with experience in PET reviewed the patients' scans in a blinded manner and reported the scans as globally positive or negative for GCA. Tracer uptake was graded across 18 artery segments. The clinical diagnosis was confirmed at 6 months' follow-up. RESULTS: In total, 58 of 64 patients underwent TAB, and 12 (21%) of the biopsies were considered positive for GCA. Twenty-one patients had a clinical diagnosis of GCA. Compared to TAB, the sensitivity of PET/CT for a diagnosis of GCA was 92% (95% confidence interval [95% CI] 62-100%) and specificity was 85% (95% CI 71-94%). The negative predictive value (NPV) was 98% (95% CI 87-100%). Compared to clinical diagnosis, PET/CT had a sensitivity of 71% (95% CI 48-89%) and specificity of 91% (95% CI 78-97%). Interobserver reliability was moderate (κ = 0.65). Among the enrolled patients, 20% had a clinically relevant incidental finding, including 7 with an infection and 5 with a malignancy. Furthermore, 5 (42%) of 12 TAB-positive GCA patients had moderate or marked aortitis. CONCLUSION: The high diagnostic accuracy of this PET/CT protocol would support its use as a first-line test for GCA. The NPV of 98% indicates the particular utility of this test in ruling out the condition in patients considered to be at lower risk of GCA. PET/CT had benefit over TAB in detecting vasculitis mimics and aortitis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sammel AM, Hsiao E, Schembri G, et al. Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double-Blind, Cross-Sectional Study. Arthritis Rheumatol. 2019. PMID: 30848549. doi:10.1002/art.40864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。